Skip to content
HirschiK

Regulation of Endothelial Cell Specialization

April 1, 2021

KAREN HIRSCHI, PH.D.

Department of Cell Biology
University of Virginia

KAREN HIRSCHI -

Karen K. Hirschi initially studied nutritional biochemistry, receiving her BS in this field at The Pennsylvania State University and her PhD at the University of Arizona. She then did postdoctoral training in vascular cell and developmental biology at Harvard Medical School, and began her first tenure-track faculty position at Baylor College of Medicine, where she became a Professor and was the founding Deputy Director of the Stem Cell and Regenerative Medicine Center. Dr. Hirschi then moved to Yale University as a Professor in the Departments of Medicine and Genetics. She remains an Adjunct Professor and a member of the Cardiovascular Research Center at Yale, but moved most of her lab to the University of Virginia (UVA) in the summer of 2019. Dr. Hirschi became the Alumni Professor of Cell Biology at the UVA School of Medicine, and is working to establish a Developmental Genomics Center that will focus on identifying genetic mutations that cause fetal and neonatal disorders. The Hirschi lab is primarily interested in vascular and hematopoietic development. They are focused on elucidating regulators of endothelial and blood cell commitment, differentiation and specialization, as well as modulators of endothelial cell cycle state during embryonic development. The Hirschi lab uses the mouse model system to study the regulation of these processes in vivo. Insights gained are applied to the modulation of the commitment of pluripotent human stem cells toward vascular and blood cell fates, and to the genesis and optimization of clinically relevant strategies to promote endogenous vascular regeneration and vascularize engineered tissues.

PRESENTATION -

Related manuscripts:

Marcelo, K.L., T. Sills, S. Coskun, H. Vasavada, S. Sanglikar, L.C. Goldie and K.K. Hirschi. (2013) Hemogenic endothelial cell specification requires c-Kit, Notch signaling and p27-mediated cell cycle control. Developmental Cell 27:504-515. https://pubmed.ncbi.nlm.nih.gov/24331925/.

Fang, J., B. Coon, Gillis, N., Qui, J., Chen, Z., Chittenden, T.W., J. Burt, M. Schwartz and K.K. Hirschi. (2017) Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nature Communications 8:2149. https://pubmed.ncbi.nlm.nih.gov/29247167/.

Qiu, J. S. Nordling, H.H. Vasavada, E.C. Butcher and K.K. Hirschi. (2020) Retinoic acid promotes endothelial cell cycle early G1 state to enable human hemogenic endothelial cell specification. Cell Reports 33:108465. https://doi.org/10.1016/j.celrep.2020.108465.

Chavkin, N.W., G. Gene, M. Poulet, N. Genet, C. Marziano, H. Vasavada, E. Nelson, A. Kour, S. McDonnell, M. Huba, K. Walsh and K.K. Hirschi. (2020) Endothelial cell cycle state determines propensity for arterial-venous fate. Bio Rxiv doi: https://doi.org/10.1101/2020.08.12.246512.

REGISTRATION -

All participants will be required to register. Current NAVBO members in good standing can register for free, however, the registration form must be completed.  Non-members will be charged a $25 fee for each webinar.  Please be sure to follow the instructions in your confirmation email - you must also register at the GoToWebinar site.  Once registration is complete, each registrant will receive a link and unique pin to join the meeting.  We are using GoToWebinar.  The confirmation email will include information about accessing the webinar.

If you have any questions, please contact bernadette@navbo.org.

Archives